Workflow
MetLife(MET)
icon
Search documents
MetLife (MET) 2025 Conference Transcript
2025-09-03 15:07
Financial Data and Key Metrics Changes - The company reported a return on equity (ROE) of 15.2% last year, with a new target of 15% to 17% under the New Frontier strategy, indicating a strong improvement from the previous target of 12% to 14% [5][10] - Group sales grew by 9% in the first half of the year, with liability balances increasing by 6%, surpassing the previously committed range of 3% to 5% [9][10] Business Line Data and Key Metrics Changes - The group benefits business raised its premium and fee growth target to 4% to 7% from 4% to 6%, reflecting confidence in driving top-line growth [16] - The retirement income solutions (RIS) business achieved a 6% growth in total liability balances in the second quarter, with expectations to remain within the 3% to 5% growth range for the year [29] Market Data and Key Metrics Changes - In Asia, sales increased by 10% in Japan and over 40% in Korea during the first half of the year, driven by demographic and economic shifts [38] - The company has seen strong growth momentum in Latin America, with earnings more than doubling since the pandemic, and a target of reaching $1 billion in earnings [46][50] Company Strategy and Development Direction - The New Frontier strategy focuses on extending leadership in group benefits, leveraging global retirement platforms, accelerating growth in MetLife Investment Management, and expanding presence in key international markets [6][7] - The company aims to reach $1 trillion in assets under management (AUM) for MetLife Investment Management [6] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the execution of the New Frontier strategy, highlighting strong early momentum and strategic initiatives such as acquisitions and reinsurance transactions [8][10] - The company anticipates continued strong performance in the second half of the year, particularly in group benefits and retirement income solutions [22][30] Other Important Information - The company launched Chariot Re, a Bermuda-based reinsurer, to augment capital generation and support growth opportunities in retirement solutions [35][37] - The implementation of the economic solvency ratio (ESR) in Japan is expected to have a seamless transition for the company, with no significant impact on dividend capacity [43][45] Q&A Session Summary Question: What are the plans to improve the direct expense ratio? - Management plans to reduce the direct expense ratio by 100 basis points over the next five years, with an evenly distributed reduction expected [11][12] Question: How is the group benefits business driving growth? - The company is focusing on adding more products for existing employers and increasing employee participation, leveraging its comprehensive product portfolio [18][21] Question: What is the outlook for the retirement income solutions business? - The RIS business is expected to maintain a healthy growth trajectory, benefiting from diversification and demographic trends [29][30] Question: How is the company managing capital allocation? - The company prioritizes organic growth, strategic M&A, and maintaining an attractive dividend yield, with a history of significant buybacks [57][60]
养老金风险转移(PRT)市场对我国二、三支柱发展的启示|财富与资管
清华金融评论· 2025-08-13 08:55
Core Viewpoint - The article discusses the development of pension risk management in Europe and the United States, aiming to provide insights for the development of the second and third pillars of pension insurance in China [2]. Group 1: Pension Risk Transfer (PRT) Overview - PRT is a financial arrangement where companies transfer the payment responsibilities of defined benefit (DB) pension plans to insurance companies, aiming to reduce risks such as longevity risk, investment risk, and interest rate risk [4][5]. - The emergence of the PRT market in Europe and the U.S. is driven by multiple factors, including aging populations, accounting standards requiring market value measurement of pension liabilities, and the complexity of pension asset-liability management [5][6]. Group 2: Historical Development Stages - Initial Stage (Pre-1980s): Pension plans evolved from informal commitments to structured DB plans, with companies facing increasing financial pressure due to aging populations and investment volatility [8]. - Emergence Stage (1980-2000): The introduction of regulatory frameworks like ERISA in the U.S. and the establishment of PBGC laid the groundwork for PRT transactions, with early examples like General Motors' group annuity transaction [9][10]. - Growth Stage (2000-2015): The PRT market saw accelerated development due to advancements in actuarial technology and regulatory support, with significant transactions such as General Motors transferring $25 billion in pension liabilities [14][15]. - Boom Stage (2015-2025): The U.S. and U.K. markets experienced explosive growth in PRT transactions, with notable deals like AT&T's $31 billion transaction in 2022, pushing annual PRT transaction volumes to new highs [16][17]. Group 3: PRT Mechanisms - Buy-in: Companies purchase annuity contracts from insurers to cover pension liabilities while retaining legal responsibility on their balance sheets [22]. - Buy-out: Companies transfer pension liabilities to insurers, removing these liabilities from their balance sheets entirely [22]. - Longevity Swap: A financial agreement that transfers longevity risk from pension plans to insurers, which can further transfer this risk to reinsurers [22][23]. Group 4: Role of Insurance Companies - Insurance companies play a crucial role in the PRT process by taking on pension liabilities and managing longevity risk through various financial instruments, thus transforming their role from asset managers to long-term liability bearers [26][28]. - The development of a multi-layered risk transfer structure involving insurers and reinsurers enhances the capacity for managing longevity risk and supports the evolution of pension systems [28]. Group 5: Challenges in China - China's pension system primarily relies on defined contribution (DC) plans, lacking the historical context of DB plans that facilitate risk transfer, leading to a deficiency in systematic longevity risk management capabilities [30][31]. - The absence of a robust regulatory framework specifically addressing pension liabilities and longevity risk hampers the development of a comprehensive risk management system in China's insurance industry [30]. Group 6: Recommendations for Development - To establish a pension risk transfer mechanism in China, it is suggested to leverage the third pillar of the pension system, focusing on transforming individual accounts into lifetime annuity products [36][38]. - The creation of a national pension reinsurance platform is recommended to facilitate risk sharing and enhance the capacity of insurance companies to provide long-term guarantees [38].
MetLife(MET) - 2025 Q2 - Quarterly Report
2025-08-07 20:21
Financial Performance - Total revenues for Q2 2025 were $17,340 million, a decrease of 2.7% compared to $17,823 million in Q2 2024[20] - Net income attributable to MetLife, Inc. for Q2 2025 was $729 million, down from $946 million in Q2 2024, representing a decline of 22.9%[20] - Premiums collected in Q2 2025 amounted to $10,810 million, a decrease of 7.0% from $11,628 million in Q2 2024[20] - Basic earnings per share for Q2 2025 were $1.04, down from $1.28 in Q2 2024, a decrease of 18.8%[20] - Comprehensive income attributable to MetLife, Inc. for Q2 2025 was $1,118 million, compared to a loss of $19 million in Q2 2024[20] - Net income for the first half of 2025 was $1,674 million, compared to $1,613 million in the same period of 2024, representing a 3.8% increase[24] - Comprehensive income for the first half of 2025 was $2,402 million, compared to $1,084 million in the first half of 2024, showing a significant increase of 121.1%[24] - Total consolidated adjusted earnings for the six months ended June 30, 2025, were $2,808 million, a decrease from $3,063 million in the same period of 2024, reflecting a decline of 8.3%[71] - The company reported a net income of $1,685 million for the six months ended June 30, 2025, down from $1,828 million in 2024, a decrease of 7.8%[71] Assets and Liabilities - Total assets increased to $702,470 million as of June 30, 2025, compared to $677,457 million at the end of 2024, reflecting a growth of 3.8%[17] - Total liabilities increased to $674,543 million, compared to $649,754 million at the end of 2024, marking a rise of 3.8%[17] - Policyholder account balances rose to $232,433 million, up 5.5% from $221,445 million at the end of 2024[17] - Total stockholders' equity as of June 30, 2025, was $27,927 million, up from $27,540 million at the end of June 2024, indicating a growth of 1.4%[23] - The company's future policy benefits liabilities totaled $198,965 million as of June 30, 2025, up from $193,646 million at the end of 2024, representing an increase of 2.3%[74] Investment Income - The company reported net investment income of $5,661 million in Q2 2025, an increase of 8.8% from $5,205 million in Q2 2024[20] - Net investment income for the six months ended June 30, 2025, was $8,164 million, up from $7,481 million in 2024, indicating an increase of 9.1%[71] - Net investment income for the three months ended June 30, 2025, was $310 million, slightly down from $313 million in the same period of 2024, indicating a decrease of about 1%[66] Segment Performance - The Group Benefits segment offers a wide range of products including life insurance and disability insurance, contributing significantly to the company's revenue[40] - The Retirement and Income Solutions segment provides various life and annuity-based products, enhancing the company's investment management capabilities[41] - The Asia segment continues to expand its offerings in life insurance and retirement savings, targeting both individuals and corporations[42] - Adjusted earnings for the Group Benefits segment in Q2 2025 were $400 million, compared to $533 million in Q2 2024, reflecting a decline of approximately 25%[66] - The Asia segment generated adjusted earnings of $350 million in Q2 2025, down from $449 million in Q2 2024, a decrease of approximately 22%[66] - Total segment revenues for the six months ended June 30, 2025, were $36,372 million, compared to $35,281 million in 2024, reflecting a growth of 3.1%[71] Cash Flow and Capital Management - Net cash provided by operating activities for the six months ended June 30, 2025, was $6,449 million, an increase from $5,818 million in 2024, representing an increase of 10.8%[25] - Cash flows from investing activities resulted in a net outflow of $6,303 million for the six months ended June 30, 2025, compared to a net outflow of $3,967 million in 2024, indicating a significant increase in investment activity[25] - Treasury stock acquired in connection with share repurchases for the first half of 2025 amounted to $2,939 million, compared to $2,046 million in the same period of 2024, representing a 43.6% increase[24] Future Outlook - The company anticipates continued challenges in the economic environment, impacting future performance and financial results[10] - The acquisition of PineBridge Investments is expected to close by the end of 2025, with a total transaction value of $1.2 billion, including $800 million in cash at closing[72] Accounting and Reporting - The company is evaluating the impact of recent accounting standards updates on its consolidated financial statements, which may affect future disclosures and financial reporting[37]
MetLife Q2 Earnings Lag Estimates on Soft MetLife Holdings Unit
ZACKS· 2025-08-07 16:06
Core Insights - MetLife, Inc. reported second-quarter 2025 adjusted operating earnings per share (EPS) of $2.02, missing the Zacks Consensus Estimate by 7.8% and declining 11% year over year [1][11] - Adjusted operating revenues decreased 4.1% year over year to $17.9 billion, also missing the consensus mark by 2.6% [1][11] Financial Performance - Weaker quarterly results were attributed to poor performance in Asia, lower underwriting results, less favorable investments, and declining earnings in group benefits, RIS, and MetLife Holdings [2][11] - Adjusted PFOs, excluding pension risk transfer (PRT), were $12.4 billion, growing 5% year over year [3] - Adjusted net investment income increased by 1% year over year to $5.2 billion due to asset growth [3] - Total expenses were $16.4 billion, down 1.6% year over year, driven by decreased policyholder benefits and claims [4] - Net income fell 23% year over year to $698 million, with adjusted return on equity deteriorating 270 basis points to 14.6% [4] Segment Performance - Group Benefits: Adjusted earnings declined 25% year over year to $400 million, below the consensus estimate of $468.6 million [5] - RIS: Adjusted earnings totaled $368 million, down 10% year over year, missing the consensus mark of $376.2 million [6] - Asia: Adjusted earnings fell 22% year over year to $350 million, lagging behind the consensus estimate of $397.6 million [7] - Latin America: Adjusted earnings rose 3% year over year to $233 million, exceeding the consensus mark of $227 million [8] - EMEA: Adjusted earnings advanced 30% year over year to $100 million, surpassing the consensus estimate of $76.1 million [9] - MetLife Holdings: Adjusted earnings decreased 5.9% year over year to $144 million, beating the consensus mark of $142.1 million [10] Financial Position - As of June 30, 2025, MetLife had cash and cash equivalents of $22.2 billion, up from $20.1 billion at the end of 2024 [13] - Total assets increased to $702.5 billion from $677.5 billion at the end of 2024 [13] - Long-term debt rose to $15.4 billion from $15.1 billion as of December 31, 2024 [13] - Total equity was $27.9 billion, up from $27.7 billion at the end of 2024 [13] - Book value per share grew 7.5% year over year to $35.79 [14] Capital Deployment - MetLife repurchased shares worth approximately $510 million in the second quarter and an additional $140 million in July 2025 [15] - The company paid a dividend of $382 million during the quarter [15] Future Outlook - Management expects variable investment income of around $1.7 billion for 2025 and anticipates Corporate & Other adjusted losses between $850 million and $950 million [16] - Adjusted PFOs in Group Benefits are projected to rise 4-7% annually over the next three years [17] - MetLife aims for an adjusted return on equity in the range of 15-17% and expects free cash flow to exceed $25 billion [18]
MetLife(MET) - 2025 Q2 - Earnings Call Transcript
2025-08-07 14:02
Financial Data and Key Metrics Changes - Adjusted earnings for Q2 2025 were reported at $1.4 billion or $2.2 per share, reflecting a 16% decrease year-over-year due to less favorable underwriting and lower investment margins [8][21] - The adjusted return on equity was 14.6%, above the cost of capital and near the mid-teen target range [9] - Free cash flow allowed the company to return approximately $900 million to shareholders through dividends and share repurchases [9][18] Business Segment Data and Key Metrics Changes - Group Benefits adjusted earnings were $400 million, down 25% from the previous year due to less favorable life and non-medical health underwriting [10][22] - Retirement and Income Solutions (RIS) reported adjusted earnings of $368 million, down 10% year-over-year, primarily due to lower recurring interest margins [12][24] - Asia adjusted earnings were $350 million, down 22% year-over-year, with sales up 9% on a constant currency basis [14][26] - Latin America adjusted earnings totaled $233 million, up 3% and 15% on a constant currency basis, driven by volume growth [28] - EMEA posted adjusted earnings of $100 million, up 30% year-over-year, primarily due to strong volume growth [29] Market Data and Key Metrics Changes - Total liability exposures increased by 6% year-over-year, driven by growth in UK longevity reinsurance [13] - General account assets under management in Asia rose by 6% year-over-year on a constant currency basis [14][27] - Adjusted premiums, fees, and other revenues in Group Benefits grew by 4% from a year ago [10][23] Company Strategy and Development Direction - The company is executing its "new frontier growth strategy," focusing on managing expenses, returning capital to shareholders, and capitalizing on market trends [7][19] - Strategic partnerships, such as with Workday, aim to enhance the benefits experience and drive sales growth [11] - Recent acquisitions and strategic transactions, including Pinebridge Investments and Chariot Re, are expected to support growth in investment management [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver on commitments despite the current economic environment [7] - The company anticipates improvements in underwriting and investment margins in the upcoming quarters [39] - Management noted that the current quarter's earnings do not fully reflect the company's earnings power, with expectations for better performance in the second half of the year [36] Other Important Information - The company repurchased approximately $500 million of its common stock in Q2, bringing the total year-to-date repurchases to over $2 billion [18][34] - Cash and liquid assets at holding companies were reported at $5.2 billion, exceeding the target buffer range [18][34] - The effective tax rate on adjusted earnings was approximately 24%, at the bottom end of the guidance range [30] Q&A Session Summary Question: Observations on elevated claims in the non-medical health sector - Management indicated that the elevated claims were not surprising and attributed them to normal fluctuations, expecting improvements in the third and fourth quarters [38][39] Question: Outlook for Chariot Re and sidecars - Management sees Chariot Re as a growth vehicle, focusing on MetLife-originated liabilities and expects more transactions in the future [44][46] Question: Strong sales in Japan and Korea - Management highlighted strong sales performance driven by new product launches and expects this momentum to continue [49][50] Question: Stability of retirement spreads - Management expects core spreads to remain stable, with some seasonal impacts anticipated in Q3 [54][56] Question: Analysis of disability claims - Management clarified that the pressure on disability claims was due to specific high-value claims and not indicative of broader trends [61][63] Question: Update on the PRT market - Management noted a lighter quarter for PRT but expects jumbo cases to transact in the second half of the year, maintaining a disciplined pricing approach [95][97] Question: Implementation of Gen AI - Management expressed excitement about AI's potential, emphasizing ongoing investments in technology to enhance efficiency and drive growth [100][102]
MetLife(MET) - 2025 Q2 - Earnings Call Transcript
2025-08-07 14:00
Financial Data and Key Metrics Changes - Adjusted earnings for the second quarter were reported at $1.4 billion or $2.2 per share, reflecting a 16% decrease year-over-year due to less favorable underwriting and investment margins [7][21] - The adjusted return on equity was 14.6%, well above the cost of capital and near the mid-teen target range [8] - Free cash flow allowed the company to return approximately $900 million to shareholders through dividends and share repurchases [8][18] Business Segment Data and Key Metrics Changes - Group Benefits adjusted earnings were $400 million, down 25% from the previous year due to less favorable life and non-medical health underwriting [8][22] - Retirement and Income Solutions (RIS) reported adjusted earnings of $368 million, down 10% year-over-year, primarily due to lower recurring interest margins [11][24] - Asia adjusted earnings were $350 million, down 22% year-over-year, with sales up 9% on a constant currency basis [13][26] - Latin America adjusted earnings totaled $233 million, up 3% and 15% on a constant currency basis, driven by volume growth [14][28] - EMEA adjusted earnings were $100 million, up 30% on both a reported and constant currency basis, primarily due to strong volume growth [15][29] Market Data and Key Metrics Changes - Total liability exposures increased by 6% year-over-year, exceeding the 2025 outlook range of 3% to 5% [12] - In Japan, sales increased by 29% on a constant currency basis, while Korea saw a 36% increase year-over-year [13][50] - EMEA's quarterly run rate is expected to remain above its 2025 guidance of $70 million to $75 million for the remainder of the year [29] Company Strategy and Development Direction - The company is executing its "New Frontier" growth strategy, focusing on managing expenses, returning capital to shareholders, and capitalizing on market trends [6][19] - Strategic partnerships, such as with Workday, are aimed at enhancing the benefits experience and driving sales growth [10][15] - Recent acquisitions and partnerships, including Pinebridge Investments and Chariot Re, are expected to support growth in the investment management platform [16][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver on commitments despite the current economic environment [6] - The company anticipates improvements in underwriting and investment margins in the upcoming quarters [39][72] - Management noted that the current quarter's results do not fully reflect the company's earnings power, with expectations for better performance in the second half of the year [19][36] Other Important Information - The company has repurchased approximately $2 billion of its common stock year-to-date, with a total of nearly $16 billion repurchased since 2021 [18][34] - Cash and liquid assets at holding companies were reported at $5.2 billion, exceeding the target buffer range [18][34] - The effective tax rate on adjusted earnings was approximately 24%, at the bottom end of the 2025 guidance range [30] Q&A Session Summary Question: Observations on elevated claims in the sector - Management indicated that the elevated claims were not surprising and expected improvements in the non-medical health ratio in the upcoming quarters [38][39] Question: Outlook for Chariot Re and growth opportunities - Management views Chariot Re as a vehicle for growth, focusing on MetLife-originated liabilities and anticipating more transactions [44][46] Question: Strong sales in Japan and Korea - Management reported strong sales performance driven by new product launches and expects to remain at the top end of guidance for Asia sales [49][52] Question: Stability of retirement spreads - Management expects core spreads to remain stable, with some seasonality anticipated in Q3 [53][56] Question: Analysis of disability claims - Management clarified that the pressure on disability claims was related to specific clients and not indicative of broader trends [61][62] Question: Update on commercial mortgage loan reserves - Management acknowledged an increase in reserves for commercial mortgages, indicating it reflects stabilization in the market [65][66] Question: Implementation of Gen AI - Management expressed excitement about the potential of AI, highlighting ongoing investments and improvements in processes to leverage emerging technologies [98][100]
MetLife(MET) - 2025 Q2 - Earnings Call Presentation
2025-08-07 13:00
2Q25 Supplemental Slides1 John McCallion Chief Financial Officer and Head of MetLife Investment Management 1 These slides highlight information in MetLife, Inc.'s earnings release, quarterly financial supplement and other prior public disclosures. Table of contents | Topic | Page No. | | --- | --- | | Net income (loss) to adjusted earnings | 3 | | Adjusted earnings by segment and Corporate & Other (C&O) | 4 | | Variable investment income (VII) | 5 | | Direct expense ratio | 7 | | Cash & capital | 8 | | Appe ...
MetLife Pet Insurance Named “Pet Insurance of the Year” In 2025 Pet Innovation Awards
GlobeNewswire News Room· 2025-08-07 12:01
Core Insights - MetLife Pet Insurance has been awarded "Pet Insurance of the Year" at the 2025 Pet Innovation Awards, recognizing its innovative contributions to the pet care industry [1][6]. Company Features - MetLife offers comprehensive pet insurance that includes optional preventive care coverage, covering services such as flea and tick control, spay/neuter, heartworm prevention, teeth cleaning, and vaccinations [2]. - The insurance plans are highly customizable, allowing pet owners to select deductibles, annual benefit limits, and reimbursement percentages tailored to their needs [2]. - Unique to MetLife is the family plan feature, which allows up to three pets to be covered under the same policy and share a deductible, a service not offered by other providers [3]. Technological Integration - MetLife provides a mobile app for policy management, health record tracking, claims submission, and access to a 24/7 vet chat, enhancing the customer experience [4]. - The company also has a rewards program that offers discounts and promotions on pet care-related purchases for eligible policyholders [4]. Industry Context - The total expenditure in the US pet industry is $157 billion, reflecting a growing trend of pet humanization where owners seek products and services that promote their pets' health and well-being [5]. - The Pet Innovation Awards highlight innovative solutions and products in the pet care sector, covering areas such as nutrition, wellness, grooming, and safety [5][7].
MetLife (MET) Q2 EPS Falls 11%
The Motley Fool· 2025-08-07 04:50
Core Insights - MetLife reported Q2 2025 results that fell short of Wall Street expectations, with non-GAAP earnings per share at $2.02 compared to the anticipated $2.15, and GAAP revenue at $17.34 billion versus the expected $18.53 billion [1][5] - The company experienced a decline in net income, which dropped to $698 million from $912 million in Q2 2024, reflecting a 23.4% year-over-year decrease [2][5] - Despite profitability pressures, book value per share increased by 7% to $35.79, and adjusted book value per share rose by 6% to $56.23, indicating strength in capital management [1][13] Financial Performance - Non-GAAP EPS was $2.02, missing estimates by 6%, while revenue of $17.34 billion was 2.7% lower than the previous year [2][5] - Net income (GAAP) decreased by 23.4% year-over-year, highlighting challenges in profitability [2][5] - The overall expense ratio increased to 19.8% from 17.9% in the previous year, although the direct expense ratio remained steady at 11.7% [11] Segment Analysis - Group Benefits segment saw adjusted earnings drop 25% to $400 million due to unfavorable underwriting conditions, despite a 4% growth in premium and fee revenue [6] - Retirement and Income Solutions segment's adjusted earnings fell 10% to $368 million, attributed to lower recurring interest margins, although premium revenue excluding pension risk transfer rose by 24% [7] - International operations showed mixed results, with Asia's adjusted earnings declining 22% to $350 million, while Latin America and EMEA segments reported gains of 3% and 30% respectively [8] Strategic Initiatives - MetLife's strategic focus includes international expansion, risk transfer arrangements, and technology investments, with the "New Frontier" strategy aimed at enhancing group benefits and asset management operations [4] - The company entered an agreement with Talcott Financial Group to reinsure variable annuity reserves, reducing market risk exposure [12] - Shareholder returns remained strong, with $900 million returned through buybacks and dividends, reflecting confidence in the company's financial health [12][15] Outlook - Management did not provide explicit financial guidance for the remainder of fiscal 2025 but expressed confidence in the company's strategic direction [14] - Key areas for investors to monitor include trends in variable investment income, underwriting results in core segments, and the success of the New Frontier strategic plan [15]
Compared to Estimates, MetLife (MET) Q2 Earnings: A Look at Key Metrics
ZACKS· 2025-08-06 23:32
Core Insights - MetLife reported $17.92 billion in revenue for Q2 2025, a year-over-year decline of 4.1%, with EPS of $2.02 compared to $2.28 a year ago [1] - The revenue fell short of the Zacks Consensus Estimate of $18.39 billion, resulting in a surprise of -2.58%, while the EPS also missed the consensus estimate of $2.19 by -7.76% [1] Financial Performance Metrics - Adjusted Revenue from EMEA for Universal life and investment-type product policy fees was $84 million, exceeding the average estimate of $79.75 million, marking a +9.1% year-over-year change [4] - Adjusted Revenue from Corporate & other for Premiums was $8 million, below the average estimate of $8.73 million, reflecting a -46.7% year-over-year decline [4] - Adjusted Revenue from EMEA for Other Revenues was $9 million, surpassing the estimated $8.44 million, showing a +12.5% year-over-year increase [4] - Adjusted Revenue from Corporate & other for Other Revenues was $118 million, exceeding the average estimate of $100.33 million, representing a +21.7% year-over-year change [4] - Revenue from Premiums was $10.81 billion, below the five-analyst average estimate of $11.29 billion, indicating a -7% year-over-year decline [4] - Revenue from Other Revenues was $679 million, slightly above the estimated $656.89 million, reflecting a +6.4% year-over-year increase [4] - Revenue from Universal life and investment-type product policy fees was $1.26 billion, slightly below the average estimate of $1.28 billion, showing a -1.7% year-over-year decline [4] - Net investment income was reported at $5.66 billion, exceeding the estimated $5.13 billion, marking an +8.8% year-over-year increase [4] - Adjusted Revenue from Retirement & Income Solutions for Premiums was $1.21 billion, significantly below the average estimate of $1.79 billion, reflecting a -50.6% year-over-year decline [4] - Adjusted Revenue from Retirement & Income Solutions for Universal life and investment-type product policy fees was $85 million, slightly below the average estimate of $90.7 million, showing a +16.4% year-over-year increase [4] - Adjusted Revenue from Retirement & Income Solutions for Net investment income was $2.15 billion, matching the average estimate, with a +1.3% year-over-year change [4] - Adjusted Revenue from Retirement & Income Solutions for Other Revenues was $60 million, slightly above the estimated $59.67 million, reflecting a -1.6% year-over-year decline [4] Stock Performance - MetLife's shares have returned -6% over the past month, contrasting with the Zacks S&P 500 composite's +0.5% change, indicating potential underperformance in the near term [3]